CME Group said it held its May 8, 2025 Annual Meeting of Shareholders. Of the 360,382,710 shares of Class A and Class B common stock issued and outstanding as of the record date, March 10, 2025, Classes A and B shares totaling 311,658,709 (86.47%) were present in person or by proxy.

1. 01

   CME Group said it held its May 8, 2025 Annual Meeting of Shareholders. Of the 360,382,710 shares of Class A and Class B common stock issued and outstanding as of the record date, March 10, 2025, Classes A and B shares totaling 311,658,709 (86.47%) were present in person or by proxy.

2. 02

   The company reported the vote on the election of fourteen Equity Directors, voted on by Class A and Class B shareholders together as a single class. Terrence A. Duffy received 257,017,436 votes for and 30,433,594 against, and Phyllis M. Lockett received 170,012,222 votes for and 111,549,878 against.

3. 03

   CME Group said shareholders approved the ratification of Ernst & Young LLP as independent public accounting firm for 2025, with 289,994,511 votes for and 21,300,039 against. The advisory vote on executive compensation was also approved, with 251,216,946 votes for and 36,031,154 against.

4. 04

   The company said no quorum was reached in the elections for Class B Directors B-1, B-2 and B-3. As a result, Hobert, Mulchrone, Tierney Jr., Maloney and Cook will serve as holdovers until the 2026 Annual Meeting, and one Class B director seat, B-2, is vacant.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.